Literature DB >> 23083804

ICUD-EAU International Consultation on Bladder Cancer 2012: Pathology.

Mahul B Amin1, Jesse K McKenney, Gladell P Paner, Donna E Hansel, David J Grignon, Rodolfo Montironi, Oscar Lin, Merce Jorda, Lawrence C Jenkins, Mark Soloway, Jonathan I Epstein, Victor E Reuter.   

Abstract

CONTEXT: To present a summary of the 2nd International Consultation on Bladder Cancer recommendations on the pathology of bladder cancer using an evidence-based strategy.
OBJECTIVE: To standardize descriptions of the diagnosis and reporting of urothelial carcinoma of the bladder and help optimize uniformity between individual pathology practices and institutions. EVIDENCE ACQUISITION: A detailed Medline analysis was performed for original articles addressing bladder cancer with regard to pathology. Proceedings from the last 5 yr of major conferences were also searched. EVIDENCE SYNTHESIS: The major findings are presented in an evidence-based fashion. Large retrospective and prospective data were analyzed.
CONCLUSIONS: Providing the best management for patients with bladder neoplasia relies on close cooperation and teamwork among urologists, oncologists, radiologists, and pathologists.
Copyright © 2012 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23083804     DOI: 10.1016/j.eururo.2012.09.063

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  37 in total

1.  Impact of 2004 ISUP/WHO classification on bladder cancer grading.

Authors:  Soum D Lokeshwar; Roberto Ruiz-Cordero; Marie C Hupe; Merce Jorda; Mark S Soloway
Journal:  World J Urol       Date:  2015-04-02       Impact factor: 4.226

2.  Keratinising cystitis with intestinal metaplasia following a Crohn's vesico-intestinal fistula.

Authors:  Deepak Batura; Grigorios Mitsopoulos
Journal:  Int Urol Nephrol       Date:  2015-04-08       Impact factor: 2.370

3.  Diagnostically challenging cases: what are atypia and dysplasia?

Authors:  Joseph Sanfrancesco; J Stephen Jones; Donna E Hansel
Journal:  Urol Clin North Am       Date:  2013-02-26       Impact factor: 2.241

Review 4.  Diagnostic accuracy of C-11 choline and C-11 acetate for lymph node staging in patients with bladder cancer: a systematic review and meta-analysis.

Authors:  Seong-Jang Kim; Phillip J Koo; Kyoungjune Pak; In-Ju Kim; Keunyoung Kim
Journal:  World J Urol       Date:  2018-01-02       Impact factor: 4.226

Review 5.  The Challenge of Managing Bladder Cancer and Upper Tract Urothelial Carcinoma: A Review with Treatment Recommendations from the Spanish Oncology Genitourinary Group (SOGUG).

Authors:  Albert Font; Raquel Luque; José Carlos Villa; Montse Domenech; Sergio Vázquez; Enrique Gallardo; Juan Antonio Virizuela; Carmen Beato; Rafael Morales-Barrera; Antoni Gelabert; Sonia Maciá; Javier Puente; Gustavo Rubio; Xavier Maldonado; Begoña Perez-Valderrama; Alvaro Pinto; Ovidio Fernández Calvo; Enrique Grande; Javier Garde-Noguera; Eva Fernández-Parra; José Ángel Arranz
Journal:  Target Oncol       Date:  2019-02       Impact factor: 4.493

6.  β-Arrestins Regulate Stem Cell-Like Phenotype and Response to Chemotherapy in Bladder Cancer.

Authors:  Georgios Kallifatidis; Diandra K Smith; Daley S Morera; Jie Gao; Martin J Hennig; James J Hoy; Richard F Pearce; Isha R Dabke; Jiemin Li; Axel S Merseburger; Markus A Kuczyk; Vinata B Lokeshwar; Bal L Lokeshwar
Journal:  Mol Cancer Ther       Date:  2019-02-20       Impact factor: 6.261

7.  The Impact of Health Literacy on Surgical Outcomes Following Radical Cystectomy.

Authors:  Kristen R Scarpato; Stephen F Kappa; Kathryn M Goggins; Sam S Chang; Joseph A Smith; Peter E Clark; David F Penson; Matthew J Resnick; Daniel A Barocas; Kamran Idrees; Sunil Kripalani; Kelvin A Moses
Journal:  J Health Commun       Date:  2016-09-23

Review 8.  Challenges in the pathology of non-muscle-invasive bladder cancer: a dialogue between the urologic surgeon and the pathologist.

Authors:  Donna E Hansel; Jeremy S Miller; Michael S Cookson; Sam S Chang
Journal:  Urology       Date:  2013-03-19       Impact factor: 2.649

9.  Recommendations for the improvement of bladder cancer quality of care in Canada: A consensus document reviewed and endorsed by Bladder Cancer Canada (BCC), Canadian Urologic Oncology Group (CUOG), and Canadian Urological Association (CUA), December 2015.

Authors:  Wassim Kassouf; Armen Aprikian; Peter Black; Girish Kulkarni; Jonathan Izawa; Libni Eapen; Adrian Fairey; Alan So; Scott North; Ricardo Rendon; Srikala S Sridhar; Tarik Alam; Fadi Brimo; Normand Blais; Chris Booth; Joseph Chin; Peter Chung; Darrel Drachenberg; Yves Fradet; Michael Jewett; Ron Moore; Chris Morash; Bobby Shayegan; Geoffrey Gotto; Neil Fleshner; Fred Saad; D Robert Siemens
Journal:  Can Urol Assoc J       Date:  2016-02-08       Impact factor: 1.862

Review 10.  What are the currently available and in development molecular markers for bladder cancer? Will they prove to be useful in the future?

Authors:  Mohamed Ismat Abdulmajed; Eyüp Burak Sancak; Berkan Reşorlu; Gydhia Zuhair Al-Chalaby
Journal:  Turk J Urol       Date:  2014-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.